Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate
Keywords: EGFR-TK inhibitors; Multitarget agents; Sulforaphane; Isothiocyanate; Akt phosphorylation; EGFR-TK; epidermal growth factor receptor; EGFR-TKI; epidermal growth factor receptor inhibitor; MET; mesenchymal-epithelial transition factor; PI3K; phosphatidyl